Go Back
BeiGene
BeiGene, a venture fund established in 2010, operates in Changping, China, with a focus on Series A and Series B investments in BioTech, Healthcare, Life Science, and Medical Device sectors. The fund, led by Partner Karyn Parra, has invested in 4 companies, including Shoreline Biosciences, and has had 1 successful exit. BeiGene is known for its dedication to advancing life sciences and biotechnology. For more information, visit their website at www.beigene.com.
About
About
About
Bio
BeiGene is a life sciences, biotechnology company.
Location
Changping, China
Stage
Series A, Series B
Partner name
Karyn Parra
Bio
BeiGene is a life sciences, biotechnology company.
Location
Changping, China
Stage
Series A, Series B
Partner name
Karyn Parra
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Life Science, Medical Device
Number of investments
4
Number of exits
1
Fund Type
Venture Fund
Portfolio Companies
Shoreline Biosciences
BeiGene
BeiGene, a venture fund established in 2010, operates in Changping, China, with a focus on Series A and Series B investments in BioTech, Healthcare, Life Science, and Medical Device sectors. The fund, led by Partner Karyn Parra, has invested in 4 companies, including Shoreline Biosciences, and has had 1 successful exit. BeiGene is known for its dedication to advancing life sciences and biotechnology. For more information, visit their website at www.beigene.com.
About
Bio
BeiGene is a life sciences, biotechnology company.
Location
Changping, China
Stage
Series A, Series B
Partner name
Karyn Parra
Fund
Fund Focus
BioTech, Healthcare, Life Science, Medical Device
Number of investments
4
Number of exits
1
Fund Type
Venture Fund
Portfolio Companies
Shoreline Biosciences